中紅醫療(300981.SZ):2022年度擬向相關銀行申請綜合授信額度合計不超40億元
格隆匯2月25日丨中紅醫療(300981.SZ)公佈,公司於2022年2月23日召開第三屆董事會第七次會議、第三屆監事會第六次會議,審議通過了《關於公司及子公司2022年度向銀行申請綜合授信額度暨公司為子公司申請綜合授信額度提供擔保的議案》,其中同意公司及子公司2022年度向相關銀行申請綜合授信額度合計不超過40億元,最終以各家銀行實際審批的授信額度為準,其中以自有資產抵質押等方式向上述金融機構申請授信額度總額不超過人民幣10億元,各抵質押主體可在總抵質押額度範圍內使用;其中2022年度公司全資子公司江西中紅普林醫療製品有限公司(“江西中紅”)擬向相關銀行申請的部分綜合授信額度,將由公司向相關銀行提供合計額度不超10億元的擔保。
為便於實施上述向銀行申請授信及擔保事項,提請股東大會授權公司及江西中紅在上述授信額度及擔保額度內自行確定授信主體、抵質押主體、選擇金融機構、申請額度時所使用的具體品種、金額及期限等授信及擔保具體事宜,並授權公司法定代表人或其指定代理人及江西中紅法定代表人代表其所在公司全權簽署額度內有關的法律文件並辦理相關事宜,簽署期限自股東大會審議通過之日起至2022年12月31日。
該議案尚需提交股東大會審議並經出席會議的股東所持表決權的三分之二以上通過。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.